|
1
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun B, Zhang D, Zhang S, Zhang W, Guo H
and Zhao X: Hypoxia induces vasculogenic mimicry channel formation
and tumor invasion-related proteins expression in melanoma. Cancer
Lett. 249:188–197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paulis YW, Soetekouw PM, Verheul HM,
Tjan-Heijnen VC and Griffioen AW: Signaling pathways in
vasculogenic mimicry. Biochem Biophys Acta. 1806:18–28.
2010.PubMed/NCBI
|
|
4
|
Mishra PJ, Mishra PJ, Glod JW and Banerjee
D: Mesenchymal stem cells: Flip side of the coin. Cancer Res.
69:1255–1258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Studeny M, Marini FC, Dembinski JL,
Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE and Andreeff
M: Mesenchymal stem cells: Potential precursors for tumor stroma
and targeted-delivery vehicles for anticancer agents. J Natl Cancer
Inst. 96:1593–1603. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McLean K, Gong Y, Choi Y, Deng N, Yang K,
Bai S, Cabrera L, Keller E, McCauley L, Cho KR and Buckanovich RJ:
Human ovarian carcinoma-associated mesenchymal stem cells regulate
cancer stem cells and tumorigenesis via altered BMP production. J
Clin Invest. 121:3206–3219. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barcellos-de-Souza P, Gori V, Bambi F and
Chiarugi P: Tumor microenvironment: Bone marrow-mesenchymal stem
cells as key players. Biochim Biophys Acta. 1836:321–335.
2013.PubMed/NCBI
|
|
8
|
Annabi B, Lee YT, Turcotte S, Naud E,
Desrosiers RR, Champagne M, Eliopoulos N, Galipeau J and Béliveau
R: Hypoxia promotes murine bone-marrow-derived stromal cell
migration and tube formation. Stem Cells. 21:337–347. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nico B, Mangieri D, Crivellato E, Vacca A
and Ribatti D: Mast cells contribute to vasculogenic mimicry in
multiple myeloma. Stem Cell Dev. 17:19–22. 2008. View Article : Google Scholar
|
|
10
|
Scavelli C, Nico B, Cirulli T, Ria R, Di
Pietro G, Mangieri D, Bacigalupo A, Mangialardi G, Coluccia AM,
Caravita T, et al: Vasculogenic mimicry by bone marrow macrophages
in patients with multiple myeloma. Oncogene. 27:663–674. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mirshahi P, Rafii A, Vincent L, Berthaut
A, Varin R, Kalantar G, Marzac C, Calandini OA, Marie JP, Soria C,
et al: Vasculogenic mimicry of acute leukemic bone marrow stromal
cells. Leukemia. 23:1039–1048. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mikhailova IN, Lukashina MI, Baryshnikov
AY, Morozova LF, Burova OS, Palkina TN, Kozlov AM, Golubeva VA,
Cheremushkin EA, Doroshenko MB, et al: Melanoma cell lines as the
basis for antitumor vaccine preparation. Vestn Ross Akad Med Nauk.
37–40. 2005.(In Russian). PubMed/NCBI
|
|
13
|
Chen T, Bai H, Shao Y, Arzigian M, Janzen
V, Attar E, Xie Y, Scadden DT and Wang ZZ: Stromal cell-derived
factor-1/CXCR4 signaling modifies the capillary-like organization
of human embryonic stem cell-derived endothelium in vitro. Stem
Cells. 25:392–401. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vartanian A, Burova O, Stepanova E,
Baryshnikov A and Lichinitser MR: The involvement of apoptosis in
melanoma vasculogenic mimicry. Melanoma Res. 17:1–8. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vartanian A, Stepanova E, Grigorieva I,
Solomko E, Baryshnikov A and Lichinitser M: VEGFR1 and PKCα
signaling control melanoma vasculogenic mimicry in a VEGFR2
kinase-independent manner. Melanoma Res. 21:91–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vartanian A, Gatsina G, Grigorieva I,
Solomko E, Dombrovsky V, Baryshnikov A and Stepanova E: The
involvement of Notch signaling in melanoma vasculogenic mimicry.
Clin Exp Med. 13:201–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Conejo-Garcia JR, Buckanovich RJ, Benencia
F, Courreges MC, Rubin SC, Carroll RG and Coucos G: Vascular
leukocytes contribute to tumor vascularization. Blood. 105:679–681.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reagan MR and Kaplan DL: Concise review:
Mesenchymal stem cell tumor-homing: Detection methods in disease
model systems. Stem Cells. 29:920–927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou L, Wang X, Zhou Y, Ma H, Wang Z, He J,
Hu H, Guan W and Ma Y: Inhibitory effect and mechanism of
mesenchymal stem cells on liver cancer cells. Tumour Biol.
35:1239–1250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aghi M, Cohen KS, Klein RJ, Scadden DT and
Chiocca EA: Tumor stromal-derived factor-1 recruits vascular
progenitors to mitotic neovasculature, where microenvironment
influences their differentiated phenotypes. Cancer Res.
66:9054–9064. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang JY, Sun T, Zhao XL, Zhang SW, Zhang
DF, Gu Q, Wang XH, Zhao N, Qie S and Sun BC: Functional
significance of VEGF-a in human ovarian carcinoma: Role in
vasculogenic mimicry. Cancer Biol Ther. 7:758–766. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okuyama H, Krishnamachary B, Zhou YF,
Nagasawa H, Bosch-Marce M and Semenza GL: Expression of vascular
endothelial growth factor receptor 1 in bone marrow-derived
mesenchymal cells is dependent on hypoxia-inducible factor 1. J
Biol Chem. 281:15554–15563. 2006. View Article : Google Scholar : PubMed/NCBI
|
